Sangamo Therapeutics, Inc. (LON: 0R1D)

Sangamo Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 23, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	195	76	427	807	1,617	733
Market Cap Growth	54.56%	-82.29%	-47.07%	-50.09%	120.64%	-20.32%
Enterprise Value	186	-1	169	453	1,138	458
Last Close Price	0.94	0.43	2.49	5.63	12.18	9.12
PS Ratio	3.45	0.55	4.62	9.87	18.67	9.47
PB Ratio	4.61	1.16	1.74	2.91	4.44	2.24
P/TBV Ratio	4.61	1.16	2.49	3.88	5.56	2.85
P/FCF Ratio	-	-	-	-	14.23	-
P/OCF Ratio	-	-	-	-	12.99	-
EV/Sales Ratio	4.37	-	1.83	5.54	13.15	5.92
EV/FCF Ratio	-2.12	-	-	-	10.01	-
Debt / Equity Ratio	0.71	0.46	0.15	0.13	0.08	0.10
Debt / FCF Ratio	-	-	-	-	0.27	-
Asset Turnover	0.32	0.48	0.17	0.13	0.15	0.17
Quick Ratio	1.15	1.72	2.53	2.99	4.51	5.73
Current Ratio	1.35	1.98	2.69	3.12	4.60	5.80
Return on Equity (ROE)	-154.94%	-136.47%	-57.37%	-40.86%	-26.04%	-23.85%
Return on Assets (ROA)	-46.35%	-17.60%	-19.59%	-13.80%	-10.27%	-10.71%
Return on Capital (ROIC)	-64.79%	-27.91%	-33.04%	-23.80%	-15.93%	-15.57%
Earnings Yield	-51.64%	-267.59%	-37.37%	-16.32%	-5.48%	-9.81%
FCF Yield	-44.85%	-255.31%	-47.38%	-23.48%	7.03%	-17.01%
Buyback Yield / Dilution	-13.03%	-13.02%	-6.76%	-7.53%	-19.92%	-15.65%
Total Shareholder Return	-13.03%	-13.02%	-6.76%	-7.53%	-19.92%	-15.65%

Source: S&P Capital IQ. Standard template. Financial Sources.